pubmed-article:3225633 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C1519429 | lld:lifeskim |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C0205527 | lld:lifeskim |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C0025677 | lld:lifeskim |
pubmed-article:3225633 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:3225633 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:3225633 | pubmed:dateCreated | 1989-4-6 | lld:pubmed |
pubmed-article:3225633 | pubmed:abstractText | From 1981 through 1985 the Southwest Oncology Group (SWOG) conducted a study evaluating the natural history and the effectiveness of standard therapy in those patients with leptomeningeal carcinomatosis from non-hematologic malignancies. Twenty-six patients were evaluated for the effectiveness of treatment; those who responded to therapy by one month exhibited a median additional survival of 5.7 months and those who were not responders at one month exhibited a median additional survival of 1.8 months. We were unable to identify pre-treatment clinical characteristics which would predict for a favorable response to therapy. Aggressive treatment in some patients may be indicated, as those patients who respond to treatment may have a survival benefit. The overall prognosis in this patient group remains exceedingly poor. | lld:pubmed |
pubmed-article:3225633 | pubmed:language | eng | lld:pubmed |
pubmed-article:3225633 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3225633 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3225633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3225633 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3225633 | pubmed:month | Sep | lld:pubmed |
pubmed-article:3225633 | pubmed:issn | 0167-594X | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:RivkinS ESE | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:PughR PRP | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:EyreH JHJ | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:QuaglianaJ... | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:TaylorS ASA | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:SauseW TWT | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:CrowleyJJ | lld:pubmed |
pubmed-article:3225633 | pubmed:author | pubmed-author:MolnarBB | lld:pubmed |
pubmed-article:3225633 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3225633 | pubmed:volume | 6 | lld:pubmed |
pubmed-article:3225633 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3225633 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3225633 | pubmed:pagination | 107-12 | lld:pubmed |
pubmed-article:3225633 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:meshHeading | pubmed-meshheading:3225633-... | lld:pubmed |
pubmed-article:3225633 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:3225633 | pubmed:articleTitle | Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases--a Southwest Oncology Group study. | lld:pubmed |
pubmed-article:3225633 | pubmed:affiliation | University of Utah Medical Center. | lld:pubmed |
pubmed-article:3225633 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3225633 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3225633 | lld:pubmed |